Search results for “Familial hypercholesterolemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 210 patents, we discovered top 55 key players by total patent application. Regeneron Pharmaceuticals, Inc., Merck & Co., Inc., AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 33.33% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 29
Merck & Co., Inc.
New Jersey, United States
Patent: 23
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 18
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 10
Gemphire Therapeutics, Inc.
Michigan, United States
Patent: 8
Pfizer Products, Inc.
Connecticut, United States
Patent: 8
Ranbaxy Laboratories Ltd.
Haryana, India
Patent: 7
CymaBay Therapeutics, Inc.
California, United States
Patent: 7
T3D Therapeutics, Inc.
North Carolina, United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing HDL Therapeutics, Inc., TRUSTEES OF THE UNIV OF PENNSYLVANIA, Regeneron Pharmaceuticals, Inc. take 50.00% of patent filing during this period.
HDL Therapeutics, Inc.
United States
Patent: 4
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 3
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 2
Shenzhen Anji Kanger Medical Laboratory
Guangdong Sheng, China
Patent: 1
T3D Therapeutics, Inc.
North Carolina, United States
Patent: 1
Gemphire Therapeutics, Inc.
Michigan, United States
Patent: 1
Odessa National Medical University
Ukraine
Patent: 1
NeuroBo Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Nanchang Aidikang Clinical Inspection Office Co.,Ltd.
Jiangxi Sheng, China
Patent: 1
East Japan Institute of Technology Co. Ltd.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 18 patents in last 5 years, we discover 5 new entrants. HDL Therapeutics, Inc., Shenzhen Anji Kanger Medical Laboratory, Nanchang Aidikang Clinical Inspection Office Co.,Ltd. are the most active new entrants in this area.
HDL Therapeutics, Inc.
United States
Patent: 4
Shenzhen Anji Kanger Medical Laboratory
Guangdong Sheng, China
Patent: 1
Nanchang Aidikang Clinical Inspection Office Co.,Ltd.
Jiangxi Sheng, China
Patent: 1
East Japan Institute of Technology Co. Ltd.
Beijing Shi, China
Patent: 1
Beijing Anngeen Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 63 patents, we discovered top 5 universities and scientific research institutions by total patent application. Arabian Gulf University, Kanazawa University, Odessa National Medical University are dominant in this area. They take 55.56% of the total patent filing.
Arabian Gulf University
Bahrain
Patent: 3
Kanazawa University
Ishikawa-ken, Japan
Patent: 2
Odessa National Medical University
Ukraine
Patent: 2
The Rockefeller University
New York, United States
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: